Sorin (Milan, Italy), a global medical device company specializing in the treatment of cardiovascular diseases, and Cyberonics (Houston), a medical device company with core expertise in neuromodulation, reported a merger plan to create a new company with a combined equity value of around $2.7 billion (€2.4 billion) based on Wednesday's closing price of Sorin and Cyberonics shares. Read More
